[Free-radical lipid peroxidation in acute myocardial infarction complicated by cardiogenic shock]. 1986

A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov

The pattern of variation in primary and end products of erythrocyte lipid peroxidation (LPO) was examined in 131 patients with acute myocardial infarction. The levels of LPO products were found to be increased dramatically, the magnitude and duration of the increase being dependent on the severity of cardiogenic shock complicating myocardial infarction. The changes were particularly marked in true cardiogenic shock. The level of LPO products fell significantly on day 2-3 of myocardial infarction where it stabilized until the end of the study in patients with uncomplicated infarction treated with alpha-tocopherol acetate in addition to a symptomatic therapy. This pattern is attributed to an inhibitory effect this antioxidant may have on LPO.

UI MeSH Term Description Entries
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
January 1995, Journal of thrombosis and thrombolysis,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
February 2019, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
February 2017, Herz,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
November 1983, Wiadomosci lekarskie (Warsaw, Poland : 1960),
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
December 2016, The Journal of invasive cardiology,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
January 2001, Acta medica (Hradec Kralove),
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
March 2019, Circulation,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
January 2000, Cardiology in review,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
June 2020, The American journal of cardiology,
A Zh Rysmendiev, and B Sh Tukesheva, and I P Grabarova, and K M Iskakov
January 2019, Open heart,
Copied contents to your clipboard!